NASDAQ:NAOV NanoVibronix (NAOV) Stock Forecast, Price & News $3.74 +0.24 (+6.86%) (As of 06/2/2023 ET) Add Compare Share Share Today's Range$3.46▼$3.7450-Day Range$3.11▼$4.0052-Week Range$2.94▼$15.40Volume4,557 shsAverage Volume6,946 shsMarket Capitalization$6.21 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileProfileChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaProfileChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media About NanoVibronix (NASDAQ:NAOV) StockNanoVibronix, Inc. engages in the development of noninvasive biological response-activating devices. The firm's products include UroShield and PainShield. It operates through the following geographical segments: United States, Europe, Australia, India, Israel, and Other. The company was founded by Harold Jacob and Jona Zumeris in September 2003 and is headquartered in Elmsford, NY.Read More Receive NAOV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for NanoVibronix and its competitors with MarketBeat's FREE daily newsletter. Email Address NAOV Stock News HeadlinesMay 28, 2023 | americanbankingnews.comNanoVibronix (NASDAQ:NAOV) and Invacare (NYSE:IVCRQ) Head-To-Head ReviewMarch 28, 2023 | finance.yahoo.comNanoVibronix Receives Positive Final Results of Independent Lifecycle Testing of PainShield Prompted by Centers for Medicare and Medicaid Services (CMS)June 3, 2023 | Legacy Research (Affiliate) (Ad)“You need at least $100 of this asset – and it’s NOT gold” – Dr. Nomi Prin$100 is all you need… Former Goldman Sachs managing director Dr. Nomi Prins has identified an investment she’s calling ‘the world’s hardest asset’ – and she’s recommending it to friends, family, and followers.March 21, 2023 | finance.yahoo.comNanoVibronix Files Provisional U.S. Patent Application for UroShield UltraMarch 14, 2023 | finance.yahoo.comNanoVibronix Announces Positive Results from Independent Product Trial of UroShield for Patients with a Spinal Cord InjuryFebruary 22, 2023 | finance.yahoo.comNanoVibronix to Launch Rental Program for PainShield and UroShieldFebruary 8, 2023 | finance.yahoo.comNanoVibronix Announces Reverse Stock SplitJanuary 18, 2023 | finance.yahoo.comNanoVibronix Provides Update on Expanding Access to PainShieldJune 3, 2023 | Legacy Research (Affiliate) (Ad)“You need at least $100 of this asset – and it’s NOT gold” – Dr. Nomi Prin$100 is all you need… Former Goldman Sachs managing director Dr. Nomi Prins has identified an investment she’s calling ‘the world’s hardest asset’ – and she’s recommending it to friends, family, and followers.December 31, 2022 | reuters.comNAOV.O - NanoVibronix Inc | Stock Price & Latest News | ReutersDecember 13, 2022 | finance.yahoo.comNanoVibronix Announces Partnership with Peak Medical, Ltd.December 9, 2022 | finance.yahoo.comShareholders Will Likely Find NanoVibronix, Inc.'s (NASDAQ:NAOV) CEO Compensation AcceptableDecember 1, 2022 | finance.yahoo.comNanoVibronix Announces Closing of $2.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesNovember 29, 2022 | investorplace.comWhat Is Going on With NanoVibronix (NAOV) Stock Today?November 29, 2022 | finance.yahoo.comNanoVibronix Announces $2.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesNovember 28, 2022 | finance.yahoo.comNanoVibronix Receives FDA 510(k) Premarket Clearance for PainShield PlusNovember 17, 2022 | finance.yahoo.comNanoVibronix Third Quarter 2022 Earnings: US$0.034 loss per share (vs US$0.26 loss in 3Q 2021)November 16, 2022 | finance.yahoo.comNanoVibronix Announces Interim Results of Clinical Study for UroShieldNovember 16, 2022 | finance.yahoo.comInterim Results Of NanoVibronix's Uroshield Show Beneficial Effects For PatientsNovember 12, 2022 | finance.yahoo.comNanoVibronix, Inc. (NAOV) Stock Historical Prices & Data - Yahoo FinanceOctober 19, 2022 | marketscreener.comNANOVIBRONIX, INC. : Other Events, Financial Statements and Exhibits (form 8-K) - Marketscreener.comOctober 19, 2022 | seekingalpha.comNanoVibronix receives extension to satisfy Nasdaq bid price requirement - Seeking AlphaOctober 19, 2022 | businesswire.comNanoVibronix Receives Extension to Satisfy Nasdaq Price Requirement - Business WireOctober 19, 2022 | finance.yahoo.comNanoVibronix Receives Extension to Satisfy Nasdaq Price RequirementOctober 13, 2022 | streetinsider.comForm PRE 14A NanoVibronix, Inc. For: Oct 12 - StreetInsider.comSeptember 26, 2022 | markets.businessinsider.comWhy LAVA Therapeutics Shares Are Trading Higher By 97%, Here Are 49 Stocks Moving In Monday's Mid-Day Session - Markets InsiderSeptember 23, 2022 | businesswire.comNanoVibronix UroShield Approved for Sale through NHS Internal Supply Chain Contract - Business WireSee More Headlines NAOV Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart NAOV Company Calendar Last Earnings5/15/2023Today6/03/2023Next Earnings (Estimated)8/21/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Surgical appliances & supplies Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:NAOV CUSIPN/A CIK1326706 Webwww.nanovibronix.com Phone(914) 233-3004Fax914-376-6111Employees11Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-5,450,000.00 Net Margins-359.91% Pretax Margin-645.44% Return on Equity-170.17% Return on Assets-96.48% Debt Debt-to-Equity RatioN/A Current Ratio1.99 Quick Ratio1.03 Sales & Book Value Annual Sales$834,000.00 Price / Sales7.45 Cash FlowN/A Price / Cash FlowN/A Book Value$1.33 per share Price / Book2.81Miscellaneous Outstanding Shares1,662,000Free Float1,550,000Market Cap$6.21 million OptionableNot Optionable Beta0.90 Key ExecutivesBrian M. MurphyChief Executive Officer & DirectorStephen Russell BrownChief Financial OfficerHarold JacobDirector & Chief Medical OfficerItai LevinsonVP-International Sales & Global Marketing, GMLindsey HarrisonVice President-SalesKey CompetitorsSurgalignNASDAQ:SRGAConformisNASDAQ:CFMSHeart Test LaboratoriesNASDAQ:HSCSPredictive OncologyNASDAQ:POAISientraNASDAQ:SIENView All CompetitorsInsiders & InstitutionsGeode Capital Management LLCSold 207,721 shares on 5/16/2023Ownership: 0.645%Amtrust Financial Services Inc.Sold 235,741 shares on 5/1/2023Ownership: 0.747%Christopher M FashekBought 40,000 shares on 6/15/2022Total: $24,000.00 ($0.60/share)View All Insider TransactionsView All Institutional Transactions NAOV Stock - Frequently Asked Questions How have NAOV shares performed in 2023? NanoVibronix's stock was trading at $0.2520 at the beginning of 2023. Since then, NAOV stock has increased by 1,383.3% and is now trading at $3.7380. View the best growth stocks for 2023 here. When is NanoVibronix's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, August 21st 2023. View our NAOV earnings forecast. How were NanoVibronix's earnings last quarter? NanoVibronix, Inc. (NASDAQ:NAOV) announced its quarterly earnings data on Monday, May, 15th. The company reported ($0.67) EPS for the quarter. The firm had revenue of $0.35 million for the quarter. NanoVibronix had a negative net margin of 359.91% and a negative trailing twelve-month return on equity of 170.17%. When did NanoVibronix's stock split? Shares of NanoVibronix split before market open on Thursday, October 13th 2022. The 2-1 split was announced on Thursday, October 13th 2022. The newly created shares were issued to shareholders after the closing bell on Thursday, October 13th 2022. An investor that had 100 shares of stock prior to the split would have 200 shares after the split. What other stocks do shareholders of NanoVibronix own? Based on aggregate information from My MarketBeat watchlists, some companies that other NanoVibronix investors own include T2 Biosystems (TTOO), ADMA Biologics (ADMA), Co-Diagnostics (CODX), Inovio Pharmaceuticals (INO), Tonix Pharmaceuticals (TNXP), BIO-key International (BKYI), Digital Ally (DGLY), iBio (IBIO) and Inpixon (INPX). What is NanoVibronix's stock symbol? NanoVibronix trades on the NASDAQ under the ticker symbol "NAOV." Who are NanoVibronix's major shareholders? NanoVibronix's stock is owned by many different institutional and retail investors. Top institutional shareholders include Amtrust Financial Services Inc. (0.75%) and Geode Capital Management LLC (0.65%). Insiders that own company stock include Aurora Cassirer and Christopher M Fashek. View institutional ownership trends. How do I buy shares of NanoVibronix? Shares of NAOV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is NanoVibronix's stock price today? One share of NAOV stock can currently be purchased for approximately $3.74. How much money does NanoVibronix make? NanoVibronix (NASDAQ:NAOV) has a market capitalization of $6.21 million and generates $834,000.00 in revenue each year. How can I contact NanoVibronix? NanoVibronix's mailing address is 525 Executive Blvd, Elmsford NY, 10523. The official website for the company is www.nanovibronix.com. The company can be reached via phone at (914) 233-3004, via email at naov@crescendo-ir.com, or via fax at 914-376-6111. This page (NASDAQ:NAOV) was last updated on 6/3/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NanoVibronix, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.